22 Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Sonoma Pharmaceuticals Inc SNOA shares rose 24.3 percent to $8.80 in pre-market trading after the company reported the FDA clearance of Loyon Skin Descaler.
• Exar Corporation EXAR rose 22 percent to $12.95 in pre-market trading after the company agreed to be acquired by MaxLinear, Inc. MXL for $13 per share in cash.
• Athersys, Inc. ATHX rose 22 percent to $1.44 in pre-market trading. William Blair initiated coverage on Athersys with an Outperform rating.
• Catalyst Biosciences Inc CBIO rose 21.2 percent to $18.19 in pre-market trading after surging 179.52 percent on Tuesday.
• Vertex Pharmaceuticals Incorporated VRTX rose 16.5 percent to $104.50 in pre-market trading after the company disclosed that two Phase 3 studies of the tezacaftor/ivacaftor combo treatment for CF met primary endpoints. BMO Capital upgraded Vertex Pharma from Market Perform to Outperform.
• Tonix Pharmaceuticals Holding Corp. TNXP shares rose 15.5 percent to $4.78 in pre-market trading. Tonix Pharma will present the FDA Breakthrough Therapy-designated PTSD program at The MicroCap Conference on April 4, 2017.
• Ritter Pharmaceuticals Inc RTTR rose 15.4 percent to $2.25 in pre-market trading after the company reported topline results from its Ph2b/3 study for lactose intolerance treatment RP-G28.
• RH RH rose 14.9 percent to $43.65 in pre-market trading as the company reported upbeat results for its fourth quarter.
• Sangamo Therapeutics Inc SGMO rose 11.1 percent to $4.50 in pre-market trading after the company reported the presentation of new data showing 'significant reduction of tau mRNA, tau protein expression using ZFP-TF-mediated gene regulation technology.'
• Verint Systems Inc. VRNT rose 7.7 percent to $42.60 in pre-market trading after the company posted stronger-than-expected earnings for its fourth quarter.
• Egalet Corp EGLT shares rose 5.4 percent to $10 in pre-market trading. Egalet disclosed that its challenge to the FDA for MorphaBond exclusivity is still being considered.
• Viavi Solutions Inc VIAV shares rose 3.4 percent to $11.20 in pre-market trading after declining 0.55 percent on Tuesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Alliqua Biomedical Inc ALQA dropped 37.6 percent to $0.390 in pre-market trading. Alliqua BioMedical priced its 9.375 million share offering at $0.40 per share.
• F5 Networks, Inc. FFIV fell 8.6 percent to $134.48 in pre-market trading. Deutsche Bank downgraded F5 Networks from Hold to Sell.
• Depomed Inc DEPO shares fell 5.8 percent to $13.40 in pre-market trading. Depomed reported a cooperation agreement with Starboard Value LP. The company also issued a weak Q1 sales forecast.
• Skechers USA Inc SKX fell 5.3 percent to $28.37 in pre-market trading. Susquehanna downgraded Skechers from Positive to Negative.
• Viewray Inc VRAY shares fell 4.5 percent to $8.25 in pre-market trading after declining 8.76 percent on Tuesday.
• Golden Ocean Group Ltd GOGL fell 4 percent to $7.79 in pre-market trading after gaining 9.30 percent on Tuesday.
• Fang Holdings Ltd SFUN fell 4 percent to $2.66 in pre-market trading after dropping 0.36 percent on Tuesday.
• Dave & Buster's Entertainment, Inc. PLAY fell 3.6 percent to $59.98 in pre-market trading. Dave & Buster's reported better-than-expected earnings for its fourth quarter, but issued cautious outlook for 2017.
• Net 1 UEPS Technologies Inc UEPS shares fell 3.6 percent to $11.93 in the pre-market trading session after gaining 0.65 percent on Tuesday.
• Groupon Inc GRPN fell 2.5 percent to $3.86 in pre-market trading. Barclays initiated coverage on Groupon with an Underweight rating.